Finbarr P Leacy
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 09, 2025
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants.Catherine Drai, Hanneke J van der Woude, Anne J Lexmond
|Jan 18, 2025
Correction to: "Canonical causal diagrams to guide the treatment of missing data in epidemiologic studies".Margarita Moreno-Betancur, Katherine J Lee, Finbarr P Leacy
|Apr 04, 2018
On the use of the not-at-random fully conditional specification (NARFCS) procedure in practice.Daniel Mark Tompsett, Finbarr Leacy, Margarita Moreno-Betancur
|Jul 13, 2016
Germline MC1R status influences somatic mutation burden in melanoma.Carla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen
Pageof 1
Frequent Collaborators
1 joint publications
Daniel Mark Tompsett
1 joint publications
Ian R White
1 joint publications
Natapol Pornputtapong
1 joint publications
D Timothy Bishop
1 joint publications
Margarita Moreno-Betancur
1 joint publications
Catherine Drai
1 joint publications
Anne J Lexmond
1 joint publications
Tineke van den Hoorn
1 joint publications
Peter G M Mol
1 joint publications
Bruno Sepodes
